[CQM-2238] CMS136: Numerator Created: 10/07/16 Updated: 04/30/19 Resolved: 04/30/19 |
|
Status: | Closed |
Project: | eCQM Issue Tracker |
Component/s: | Measure |
Type: | EC eCQMs - Eligible Clinicians | Priority: | Minor |
Reporter: | Elissa Chandler (Inactive) | Assignee: | Mathematica EC eCQM Team |
Resolution: | Done | Votes: | 0 |
Labels: | None |
Attachments: |
![]() |
Contact Name: | Elissa Chandler |
Contact Email: | echandler@nextgen.com |
Contact Phone: | 2677255354 |
Institution/Name: | NextGen Healthcare |
Solution: | Thank you for your question. The measure assesses whether patients had a visit with a provider who has prescribing authority within 30 days of ADHD medication being dispensed (i.e., ADHD medication was prescribed by practitioner, and subsequently picked up at the pharmacy by patient or patient proxy). Therefore, in both examples, the patient would fall into the numerator 1. There are two components required for Numerator 2: 1) a face-to-face encounter within 30 days after the index prescription start date and 2) at least two follow-up visits within 31 and 300 days after the index prescription start date. Providing the medications are dispensed (as opposed to just being prescribed), both situations described in the examples would only satisfy the first component and not the second component of Numerator 2. Thus, neither example would be compliant for Numerator 2. It is important to mention that we are considering the following change: timing operator for medications changed from "ends after end of" to "starts after end of." This update would be made during the 2017 annual update cycle. |
2017 Performance Period EC eCQMs: |
CMS136v6/NQF0108
|
If your issue is regarding an older eCQM version, enter it here: | CMS136v5 |
Impact: | high impacts measure development |
Comment Posted On: |
Description |
QUESTION: CMS136v5 Per the specification for the Numerator the encounter performed “ends after end of $InitialADHDMedication”. Example1: Example2: Will your response also apply to Numerator Criteria 2 for any of the above examples? |
Comments |
Comment by Mathematica EC eCQM Team [ 02/21/17 ] |
Sorry for any confusion. In the original example that you provided, we noticed that both visits took place within the 30 day period after the first ADHD medication. In that case, patient would be non-compliant for numerator 2. Allow us to clarify our earlier response regarding end date/time. The measure does not require an end date/time for the medication. The patient can remain active on the medication during the follow-up encounter. We are only interested in the end date for the dispensing event. |
Comment by Elissa Chandler (Inactive) [ 02/01/17 ] |
Hi could we please have an ETA on this question. I added a follow-up question and have not yet heard back. thank you. |
Comment by Elissa Chandler (Inactive) [ 01/23/17 ] |
hello could we please have an ETA on this question. I added follow-up question..and have not yet heard back. |
Comment by Elissa Chandler (Inactive) [ 01/09/17 ] |
Hello, thank you for responses so far. However, our measures developer seeks further clarification. QUESTIONS My question is whether or not the medication must have a stop date prior to the encounter performed. The response that was left in the comment section suggests that the medication stop date must occur prior to an encounter performed as portrayed in their example. However, up in the solutions section, it suggests that both examples that we provided will meet numerator 1. The main difference in our examples is that one scenario has a medication stop date while the other does not have. In addition, the response in the comment section suggests that both examples that we provided will meet both Numerator 1 and Numerator 2 requirements. However, the response in the solutions section states that our examples will only meet Numerator 1 requirements. I have no opposition to that. Let me know if you have any more questions. Thanks! See below as a reference: On top in the "Solution" section, it says : " There are two components required for Numerator 2: 1) a face-to-face encounter within 30 days after the index prescription start date and 2) at least two follow-up visits within 31 and 300 days after the index prescription start date. Providing the medications are dispensed (as opposed to just being prescribed), both situations described in the examples would only satisfy the first component and not the second component of Numerator 2. Thus, neither example would be compliant for Numerator 2. It is important to mention that we are considering the following change: timing operator for medications changed from "ends after end of" to "starts after end of." This update would be made during the 2017 annual update cycle. But in the comments section, " Response to question 2: Office visit with physician: 1/20/2016 at 4 pm. To be clear, this does not mean that the medication should not be active. The patient should still be on the medication after the dispensing end date. |
Comment by Mathematica EC eCQM Team [ 01/04/17 ] |
Response to question 1: Response to question 2: Office visit with physician: 1/20/2016 at 4 pm. To be clear, this does not mean that the medication should not be active. The patient should still be on the medication after the dispensing end date. |
Comment by Elissa Chandler (Inactive) [ 12/08/16 ] |
Hello, thank you for your responses!! PLEASE SEE ATTACHMENT – with 2 follow-up questions that relate to the answers you provided. Thank you! |
Comment by Elissa Chandler (Inactive) [ 10/28/16 ] |
Hi could we receive an ETA on response...this question has urgent impact to providers and multiple stakeholders. thank you. |
Comment by Elissa Chandler (Inactive) [ 10/20/16 ] |
hi could I get an ETA this is urgent request from our team |
Comment by Elissa Chandler (Inactive) [ 10/13/16 ] |
hi do you have an ETA on response. tyvm |